Literature DB >> 33738714

CT and PET-CT Surveillance in Stages 3A to 3D Melanoma Results in More False-Positive than True-Positive Findings and Should Not be Routinely Recommended.

Nicholas A Taylor1, David G Brodland2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33738714     DOI： 10.1245/s10434-021-09820-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

Review 1.  Effective doses in radiology and diagnostic nuclear medicine: a catalog.

Authors:  Fred A Mettler; Walter Huda; Terry T Yoshizumi; Mahadevappa Mahesh
Journal:  Radiology       Date:  2008-07       Impact factor: 11.105

2.  Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.

Authors:  Jeffrey D Wagner; Donald Schauwecker; Darrell Davidson; Theodore Logan; John J Coleman; Gary Hutchins; Charlene Love; Stacie Wenck; Joanne Daggy
Journal:  Cancer       Date:  2005-08-01       Impact factor: 6.860

3.  Reply to: CT and PET/CT Surveillance in Stage IIIA-D Melanoma Results in More False-Positive Than True-Positive Findings and Should Not be Routinely Recommended, by Nicholas Taylor et al.

Authors:  Mbathio Dieng; Sarah J Lord; Omgo E Nieweg; Robyn P M Saw; Andrew J Einstein; Amanda A G Nijhuis; Robin M Turner; John F Thompson; Rachael L Morton
Journal:  Ann Surg Oncol       Date:  2021-05-02       Impact factor: 5.344

4.  Staging 18F-FDG PET/CT influences the treatment plan in melanoma patients with satellite or in-transit metastases.

Authors:  Lodewijka H J Holtkamp; Annette H Chakera; Sebastian Fung; Jonathan R Stretch; Robyn P M Saw; Kenneth Lee; Sydney Ch'ng; Maria Gonzalez; John F Thompson; Louise Emmett; Omgo E Nieweg
Journal:  Melanoma Res       Date:  2020-08       Impact factor: 3.199
  4 in total
  1 in total

1.  Reply to: CT and PET/CT Surveillance in Stage IIIA-D Melanoma Results in More False-Positive Than True-Positive Findings and Should Not be Routinely Recommended, by Nicholas Taylor et al.

Authors:  Mbathio Dieng; Sarah J Lord; Omgo E Nieweg; Robyn P M Saw; Andrew J Einstein; Amanda A G Nijhuis; Robin M Turner; John F Thompson; Rachael L Morton
Journal:  Ann Surg Oncol       Date:  2021-05-02       Impact factor: 5.344
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.